4.5 Editorial Material

Juvenile Idiopathic Arthritis: An Idea Whose Time Has Gone?

Journal

JOURNAL OF RHEUMATOLOGY
Volume 46, Issue 2, Pages 124-126

Publisher

J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.180922

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis

Sheila T. Angeles-Han, Mindy S. Lo, Lauren A. Henderson, Melissa A. Lerman, Leslie Abramson, Ashley M. Coopers, Miriam F. Parsa, Lawrence S. Zemel, Tova Ronis, Timothy Beukelman, Erika Cox, H. Nida Sen, Gary N. Holland, Hermine Brunner, Andrew Lasky, C. Egla Rabinovich

ARTHRITIS CARE & RESEARCH (2019)

Article Dentistry, Oral Surgery & Medicine

Primary Oral Presentation of Sarcoidosis in a Pediatric Patient

Chad Dammling, Peter Waite, Timothy Beukelman

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2019)

Article Rheumatology

Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis

Esraa M. Eloseily, Peter Weiser, Courtney B. Crayne, Hilary Haines, Melissa L. Mannion, Matthew L. Stoll, Timothy Beukelman, T. Prescott Atkinson, Randy Q. Cron

ARTHRITIS & RHEUMATOLOGY (2020)

Article Rheumatology

Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers

Daniel B. Horton, Jomaira Salas, Aleksandra Wec, Melanie Kohlheim, Pooja Kapadia, Timothy Beukelman, Alexis Boneparth, Ky Haverkamp, Melissa L. Mannion, L. Nandini Moorthy, Sarah Ringold, Marsha Rosenthal

Summary: When deciding whether to stop medications when JIA is inactive, patients and caregivers consider competing risks between disease activity and treatment, as well as factors such as concerns about JIA, treatment-related complications, sense of normalcy and safety, and uncertainty about future harms. They also rely on trust in healthcare providers and other information sources for decision-making.

ARTHRITIS CARE & RESEARCH (2021)

Letter Rheumatology

The patient and parent perspective on methotrexate in recent juvenile idiopathic arthritis guidelines: comment on the article by Ringold et al Reply

Sarah Ringold, Suzanne Schrandt, Emily L. Creek, Timothy Beukelman, Sheila T. Angeles-Han, Daniel J. Lovell

ARTHRITIS & RHEUMATOLOGY (2020)

Article Rheumatology

Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis

Justine Maller, Emily Fox, K. T. Park, Sarah Sertial Paul, Kevin Baszis, Charlotte Borocco, Sampath Prahalad, Pierre Quartier, Adam Reinhardt, Dieneke Schonenberg-Meinema, Lauren Shipman-Duensing, Maria Teresa Terreri, Julia Simard, Idit Lavi, Elizabeth Chalom, Joyces Hsu, Devy Zisman, Elizabeth D. Mellins

Summary: The occurrence of inflammatory bowel disease in the setting of systemic juvenile idiopathic arthritis is rare, with patients showing favorable response to tumor necrosis factor-alpha inhibitors.

JOURNAL OF RHEUMATOLOGY (2021)

Article Rheumatology

New Medications Are Needed for Children With Juvenile Idiopathic Arthritis

Hermine I. Brunner, Laura E. Schanberg, Yukiko Kimura, Anne Dennos, Dominic O. Co, Robert A. Colbert, Robert C. Fuhlbrigge, Ellen Goldmuntz, Daniel J. Kingsbury, Cathy Patty-Resk, Sandra Mintz, Karen Onel, Lisa G. Rider, Rayfel Schneider, Allen Watts, Emily von Scheven, Daniel J. Lovell, Timothy Beukelman

ARTHRITIS & RHEUMATOLOGY (2020)

Article Public, Environmental & Occupational Health

Oral Glucocorticoids and Incident Treatment of Diabetes Mellitus, Hypertension, and Venous Thromboembolism in Children

Daniel B. Horton, Fenglong Xie, Lang Chen, Melissa L. Mannion, Jeffrey R. Curtis, Brian L. Strom, Timothy Beukelman

Summary: This study found that children taking high-dose oral glucocorticoids have a higher relative risk of newly treated VTE, diabetes, and especially hypertension, but a lower absolute risk.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)

Article Rheumatology

Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry

Melissa L. Mannion, Fenglong Xie, Daniel B. Horton, Sarah Ringold, Colleen K. Correll, Anne Dennos, Timothy Beukelman

Summary: Biologic medications have greatly improved disease control and outcomes for patients with juvenile idiopathic arthritis (JIA), but a substantial number of patients may require switching to a second biologic. The time to switch has decreased in recent years, and further studies are needed to evaluate outcomes and optimal timing of biologic switching.

JOURNAL OF RHEUMATOLOGY (2021)

Article Rheumatology

Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Sacroiliitis

Dax G. Rumsey, Aimee Lougee, Roland Matsouaka, David H. Collier, Laura E. Schanberg, Jennifer Schenfeld, Natalie J. Shiff, Matthew L. Stoll, Scott Stryker, Pamela F. Weiss, Timothy Beukelman

Summary: This study described characteristics of over 900 children with ERA or juvenile PsA, highlighting high biologic use, especially in those with sacroiliitis. Equal sex representation was found in children with sacroiliitis.

ARTHRITIS CARE & RESEARCH (2021)

Article Pediatrics

Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis

Nayimisha Balmuri, William Daniel Soulsby, Victoria Cooley, Linda Gerber, Erica Lawson, Susan Goodman, Karen Onel, Bella Mehta

Summary: The study found that higher community poverty levels were associated with a longer time to pediatric rheumatologist presentation after symptom onset in children with polyarticular juvenile idiopathic arthritis.

PEDIATRIC RHEUMATOLOGY (2021)

Article Pediatrics

Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry

Timothy Beukelman, Aimee Lougee, Roland A. Matsouaka, David Collier, Dax G. Rumsey, Jennifer Schenfeld, Scott Stryker, Marinka Twilt, Yukiko Kimura

Summary: This study characterizes contemporary patterns of ETN use in the CARRA Registry. Treatment was largely in keeping with American College of Rheumatology guidelines.

PEDIATRIC RHEUMATOLOGY (2021)

Article Rheumatology

The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the United States

Timothy Beukelman, Fenglong Xie, Ivan Foeldvari

JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2019)

No Data Available